Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.

What symbol and exchange does Daxor - Closed End shares trade?

Daxor - Closed End trades on the NASDAQ stock market under the symbol DXR.

What is Daxor - Closed End stock price doing today?

As of November 6, 2026, DXR stock price declined to $8.45 with 8,311 million shares trading.

How much is Daxor - Closed End worth?

DXR has a market cap of $49.24 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Daxor - Closed End traded in the last 3 year period?

In the last 3 years, DXR traded as high as $14.76 and as low as $6.55.

What are the top ETFs holding Daxor - Closed End?

The top ETF exchange traded funds that DXR belongs to (by Net Assets): VTI.

Is Daxor - Closed End (DXR) a good investment?

DXR has underperformed the market in the last year with a price return of -35.6% while the SPY ETF gained +10.8%. DXR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -19.5% and -8.6%, respectively, while the SPY returned -4.1% and -3.2%, respectively.

What are the support and resistance levels for Daxor - Closed End (DXR)?

DXR support price is $8.22 and resistance is $9.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DXR shares will trade within this expected range on the day.